GOLGA2P3Y

Across TCGA pan-cancer cohorts, GOLGA2P3Y RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated GOLGA2P3Y data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher GOLGA2P3Y RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOLGA2P3Y expression acts as an unfavorable survival marker.

ESCA, LIHC, and LUSC are the cancer types where GOLGA2P3Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.296	0.565	<.001	84	view →
LIHC	OS	Tertile	II,III,IV	0.051	0.716	<.001	72	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
READ	DFS	Tertile	III,IV	0.514	0.746	<.001	33	view →
KIRC	OS	Tertile	All	0.660	0.885	.016	27	view →
SKCM	DFS	Tertile	All	0.210	0.615	.006	27	view →
STAD	DFS	Tertile	III,IV	0.150	0.508	.001	18	view →
LGG	DFS	Tertile	All	0.150	0.424	.003	12	view →
SARC	DFS	Tertile	All	0.098	0.591	.010	9	view →
PCPG	DFS	Tertile	All	0.382	0.863	.012	9	view →
KIRP	DFS	Tertile	All	0.235	0.614	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

GOLGA2P3Y–ESCA (DFS)

Open the ESCA breakdown →